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Abstract: The electrical properties of tissues depend on their architecture and cellular 
composition. We have previously shown that changes in electrical impedance can be used to 
differentiate between different degrees of cervical dysplasia and cancer of the cervix. In this 
proof-of-concept study, we aimed to determine whether electrical impedance spectroscopy 
(EIS) could distinguish between normal oral mucosa; benign, potentially malignant lesions 
(PML); and oral cancer. EIS data were collected from oral cancer (n=10), PML (n=27), and 
benign (n=10) lesions. EIS from lesions was compared with the EIS reading from the normal 
mucosa on the contralateral side of the mouth or with reference spectra from mucosal sites of 
control subjects (n=51). Healthy controls displayed significant differences in the EIS obtained 
from different oral sites. In addition, there were significant differences in the EIS of cancer and 
high-risk PML versus low-risk PML and controls. There was no significant difference between 
benign lesions and normal controls. Study subjects also deemed the EIS procedure consider-
ably less painful and more convenient than the scalpel biopsy procedure. EIS shows promise 
at distinguishing among malignant, PML, and normal oral mucosa and has the potential to be 
developed into a clinical diagnostic tool.
Keywords: oral cancer, head and neck cancer, potentially malignant lesions, dysplasia, imped-
ance spectroscopy
Introduction
Cancers of the lip and oral cavity are the ninth most common cancers worldwide, with 
approximately 260,000 new cases and 127,000 deaths reported in 2008.1 This year 
alone, it is estimated that there will be 28,000 new cases and 5,500 deaths in the United 
States attributable to oral squamous cell carcinoma (OSCC).2 The worldwide incidence 
is increasing,3 and the disease has a poor prognosis, with less than 55% overall 5-year 
survival.4–6 Treatment of OSCC often requires disfiguring surgical treatment and/or 
radiotherapy or chemotherapy. However, if it is detected early, the prognosis and 
outcome are considerably improved, with up to a 90% 5-year survival rate.
Many oral cancers are preceded by potentially malignant lesions (PML). Clinically, 
these present most often as white (leukoplakia) or, occasionally, red (erythroplakia) 
oral lesions affecting the oral mucosa.4 The reported incidence and prevalence of PML 
vary markedly between different regions of the world, with incidence levels ranging 
from 0.6 to 30.2/1,000 people and prevalence between 1%–5% of a given popula-
tion, depending on the location of the study.5 Although PML are relatively common, 
only a small percentage (5%–15%) progress to cancer,5,6 and although clinical signs, 
such as a nonhomogeneous surface or a stippled appearance, suggest higher risk for 
malignant transformation, there are currently no reliable clinical indicators to predict 
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which lesions will progress to cancer. Current good practice 
dictates that all suspicious oral lesions be surgically biopsied 
and subjected to histopathological assessment for evidence 
of oral epithelial dysplasia (OED). Using the World Health 
Organization (WHO) classification,7 pathologists use certain 
cell and tissue morphological characteristics to grade OED 
as no, mild, moderate, or severe dysplasia or carcinoma in 
situ. The severity of OED is currently regarded by many as 
the most reliable indicator of the risk for malignant change 
in a PML.8–10 Recently, a binary system for grading OED 
has been proposed.11 Although not widely accepted yet, 
this binary grading scheme divides lesions with OED into 
just two categories: high-risk OED and low-risk OED. The 
authors claim this reduces interobserver variability in lesion 
grading and results in better sensitivity and specificity for 
predicting which lesions with OED will undergo malignant 
change.11,12 Binary classification of OED lesions may also 
fit the needs of clinicians better when it comes to making 
critical management decisions about lesions; for example, 
should the lesion be kept under observation (low-risk OED) 
or be excised (high-risk OED)?
A major limitation to the use of biopsy and histopatho-
logical analysis for assessing PML is that most oral lesions 
show no signs of OED, so many patients may receive a 
biopsy unnecessarily. This increases the cost of managing 
PML and may have a detrimental physical and psychological 
effect on patients. Also, although the severity of OED may 
be predictive of the risk for malignant change, the grad-
ing of OED is highly subjective and liable to considerable 
inter- and intraexaminer variation.12,13 This is compounded 
by the sampling error that occurs in identifying the optimal 
site to biopsy, particularly with large or multiple lesions. 
Multiple biopsies can be difficult to perform, are invasive, 
and are often unacceptable to the patient. As a result, the 
degree of OED identified in the biopsy specimen may not 
reflect the degree of OED elsewhere in the lesion or at other 
sites in the mouth. Furthermore, the taking of a biopsy and 
its histopathological assessment are both time-consuming 
and resource-intensive. Therefore, there is considerable 
interest in the development of novel, rapid, noninvasive, 
point-of-care, quantitative methods of assessing lesions that 
are not so dependent on the subjective assessment of OED, 
which could help reduce diagnostic variability and improve 
patient care.
Patients presenting with PML pose considerable man-
agement problems for clinicians. For the majority of lesions 
that have less severe OED, management usually consists 
of watchful waiting and reduction of risk habits (smoking, 
alcohol consumption, etc), as excision of PML may not 
reduce the risk for malignant change.14 However, clinical 
observation is poor at detecting worsening OED and early 
malignant change. Although regular repeat biopsies would 
be more effective than clinical observation alone, the timing 
of these is difficult, and they are subject to the same issues 
of sampling error, subjectivity, and variability in grading. 
In addition, regular rebiopsy is costly and unpleasant for 
the patient. There would be enormous benefit in terms of 
monitoring disease progression and response to treatment, 
as well as reducing cost in having less invasive point-of-care 
assessment tools that would permit more regular longitudinal 
monitoring of PML, particularly if this can be done noninva-
sively chair side, with the results instantly available.
Several adjunctive techniques are available to aid visual 
examination of PML. These include chemiluminescence, 
acetowhite staining of tissues, tissue staining with toluidine 
blue or Lugol’s iodine, and veloscope visualization.15–18 The 
sensitivity and specificity of each of these methodologies 
is sufficiently low that they are not promoted as diagnostic 
tests in their own right but, rather, as aids to the identifica-
tion of lesions that should be subject to biopsy. Recently, 
there has been much interest in developing electrical and 
optical devices to assess oral PML. Imaging techniques such 
as optical coherence tomography and narrow band imaging 
that are able to detect changes in the cellular structure of the 
oral epithelium have been used to assess PML.19,20 Electrical 
impedance spectroscopy (EIS) has recently been developed 
as a new point-of-care diagnostic screening tool for the detec-
tion and assessment of cervical dysplasia and early cervical 
cancer.21 All biological tissues have electrical impedance that 
is a function of frequency because tissues contain components 
(cells, matrix, etc) that have both resistive and capacitive 
(charge storage) properties. Both the size of the impedance 
and the dependence of impedance on frequency are related 
to tissue composition, and so different tissue structures are 
associated with different frequency bands within an imped-
ance spectrum. At high frequencies (1 GHz), molecular 
structure is the determining factor, whereas at low frequen-
cies (100 Hz), charge accumulation at large membrane 
interfaces dominates. At frequencies of a few kilohertz to 
1 MHz, sometimes referred to as the β-dispersion region, 
cell structures are the main determinant of tissue imped-
ance. Within the β-dispersion region, low-frequency current 
passes around the cells, and the resistance to flow will depend 
on the cell spacing and cellular arrangement of the tissue. 
However, at higher frequencies, the current can penetrate 
the cell membranes, and therefore passes through cells, as 
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well as extracellular spaces. Here, the resistance to flow is 
determined by intracellular volume and nuclear size.
The relationship between tissue structure and imposed 
electrical current flow in cervical tissues has already been 
demonstrated,22–24 and EIS is able to successfully detect 
cervical cancer and precancer in these tissues.21,25 There 
are similarities between cervical cancer/precancer and oral 
cancer/PML both histologically and clinically, so this new 
method for detecting cervical epithelial dysplasia may be 
equally applicable to oral lesions. The overall objective 
of this proof-of-concept study was to determine whether 
EIS has the potential to correctly identify oral lesions in 
patients in whom the diagnosis was confirmed by biopsy 
and histopathology.
Materials and methods
This study was approved by the National Research Ethics 
Service (no. 11/H0903/4) and the University of Sheffield 
Research Ethics Committee and was conducted in compli-
ance with the Helsinki Declaration. Each subject agreed to 
participate in the study with signed, informed consent.
Study and control subjects
A total of 47 study subjects were recruited from patients 
attending the oral medicine clinic at the Charles Clifford 
Dental Hospital, Sheffield Teaching Hospitals National 
Health Service Foundation Trust, Sheffield, United 
 Kingdom. Patients were recruited in a nonconsecutive 
manner. EIS spectra were obtained from patients with 
lesions more than 8 mm in diameter and in whom the his-
topathological diagnosis was already known. Patients with 
pacemakers, those younger than 16 years, and those with 
lesions smaller than 8 mm in diameter were excluded from 
the study. The presence of OED in lesions was identified 
and graded using the WHO classification system.7 Lesions 
were categorized as having oral squamous cell carcinoma 
(n=10), severe dysplasia (n=7), moderate dysplasia (n=10), 
mild dysplasia (n=10), or benign lesions (n=10; consisting 
of lichen planus [n=4], hyperkeratosis [n=3], lichenoid 
reaction [n=2], and chronic hyperplastic candidiasis [n=1]). 
The histological tissue sections were then reanalyzed 
and the OED regraded, using the binary classification 
system,11 into OSCC (n=10), high-risk dysplasia (n=13), 
low-risk dysplasia (n=14), or benign (n=10). In a further 
analysis, we grouped the lesions with OSCC or high-risk 
dysplasia together into a high-risk lesion group (n=23) and 
those lesions that had low risk dysplasia or were benign 
into a low-risk lesion group (n=24).
In total, 75 lesional EIS spectra were available for analy-
sis. In 18 of the 47 patients, two measurements were made 
from the lesion, and in five patients, three measurements were 
made. In all cases, the mean of the measurements made from 
each lesion was used in analysis. In addition, 47 measure-
ments were made from clinically normal appearing mucosa 
at the same site as the lesion, but on the contralateral side 
of the mouth.
Controls (n=51) consisted of healthy volunteers with 
no previous history of oral mucosal disease. In the control 
subjects, EIS spectra were obtained from 12 different ana-
tomical sites in the mouth (right/left buccal mucosa, right/left 
gingiva, midline labial mucosa, vermillion, right/left lateral 
tongue, midline dorsum of tongue, midline ventral tongue, 
floor of mouth, and hard palate) to cover both keratinized and 
nonkeratinized mucosa (Figure 1). Additional demographic 
information for all subjects was also collected (Table 1).
Study subjects also completed a questionnaire after biopsy 
and after the EIS readings were taken. Individuals were asked to 
evaluate the pain or discomfort they experienced with the scal-
pel biopsy and EIS readings. They were also asked how easy/
convenient the procedures were.  Measurements were made 
Figure 1 schematic diagram showing the anatomical sites where electrical impe dance 
spectroscopy measurements were made in the normal subjects. (1) right buccal 
mucosa, (2) left buccal mucosa, (3) right gingiva, (4) left gingiva, (5) labial mucosa, (6) 
vermillion, (7) right lateral tongue, (8) left lateral tongue, (9) dorsum of tongue, (10) 
ventral tongue, (11) floor of mouth, and (12) hard palate.
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using a 100-point sliding scale chart in which 0 represented no 
discomfort or a very convenient procedure and 100 represented 
maximum discomfort or a very inconvenient procedure.
eIs measurement
The EIS device consists of a handheld unit, a base station for 
downloading data to a laptop, a single-use sheath covering the 
snout of the handheld unit, and associated software (Figure 2). 
To take oral measurements, the 5.5-mm-diameter tip of the 
sheathed snout was placed in contact with the oral lesion or 
control tissue, as described previously when taking measure-
ments of cervical mucosa.26,27 The tip of the sheathed snout 
has four gold electrodes that are set at a constant diameter and 
spacing to achieve a defined flow of current into the tissue. 
The electrodes were placed gently on the lesion or normal oral 
mucosa, and a four-electrode transfer impedance measure-
ment was made. In this process, the current (12 µA p–p) is 
passed between an adjacent pair of electrodes, and the voltage 
is then measured between the remaining pair. The frequency 
of the applied current ranges from 0.076–625 kHz in 14 binary 
steps, and the minimum time required to record the full fre-
quency spectrum is 20 ms. Measurements were only acquired 
if five internal quality control assessments were passed. Data 
were captured in real-time and immediately downloaded via 
the base station to a computer for analysis.
The median EIS spectra from all 51 control subjects were 
constructed for each of the 12 oral mucosal sites and used as 
templates to which the patient spectra for the same site were 
compared. These templates were used in a similar manner 
to those previously generated from finite element modeling 
of cervical tissues.21 Each measured spectrum from a lesion 
was matched to the normal control template generated for the 
same anatomical site as the lesion. This matching generates 
a number between -2 and +2, where 0 represents a perfect 
impedance match between lesion and control template. The 
match was calculated as twice the mean difference between 
the measured and template spectral values, divided by the 
sum of the measured and template values. The sign indicates 
whether the recorded impedance was less than (-) or greater 
Table 1 Demographic information on the normal control and 
patient study groups
Demographic Data
Normal controls (n=51)
Median age, years 44
age range, years 22–61
Male, n (%) 21 (41)
Female, n (%) 30 (59)
Patients (n=47)
Median age, years 62
age range, years 44–90
Male, n (%) 28 (59)
Female, n (%) 19 (41)
site of lesion n (%)
Ventral tongue 10 (22)
hard palate 2 (4)
lateral tongue 9 (20)
Floor of mouth 3 (7)
Buccal mucosa 10 (22)
Dorsal tongue 1 (2)
Vermillion 4 (9)
gingiva 6 (13)
labial mucosa 1 (2)
A B
Figure 2 The electrical impedance spectroscopy measurement device.
Notes: (A) handheld unit with single-use sheath. (B) handheld unit on base station. The device is operated via a small mobile phone-type display screen and toggle buttons 
mounted in the handle of the device.
International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
4525
Use of impedance spectroscopy to distinguish oral lesions
than (+) the control template. The matching only used the 
frequencies between 305–312,000 Hz, as the extreme fre-
quencies were subject to larger errors than the midfrequen-
cies. For analysis purposes, we were interested only in the 
size of the difference between the recorded impedances 
and the control template. Thus, unsigned data were used to 
produce the scatterplots and receiver operating characteristic 
(ROC) curves.
In addition to comparing lesional EIS data with that of 
normal controls, we compared lesional impedance readings 
with readings taken from an area of normal oral mucosa in 
the same patient and at the same site as the lesion, but on the 
contralateral side of the mouth (ie, an internal control).
statistical analysis
The ROC curves were plotted using MATLABTM (The 
MathWorks Inc., Natick, MA, USA). Statistically significant 
differences in the data were calculated using a two-tailed, 
nonparametric Mann–Whitney U-test, using PRISM 
6.01 (GraphPad Software Inc., La Jolla, CA, USA), and data 
were considered significantly different if P0.05.
Results
Normal control data
Of 612 measurements that were attempted from the 51  normal 
subjects, 565 spectra were recorded and 500 spectra were 
available for analysis after the application of in-built quality 
control checks by the EIS device. On the 47 occasions when 
spectra could not be recorded, it was because of difficulties in 
placing the probe such that all four electrodes made consistent 
contact with the tissue. On 65 occasions, although spectra 
were recorded, they were rejected because the impedances 
were outside the expected range of measurement. Where 
measurements were made from the same anatomical site on 
both sides of the mouth (buccal mucosa, gingiva, and lateral 
tongue), the results were combined. Figure 3 depicts the 
median spectra recorded for the nine different anatomical 
sites analyzed and shows clear differences between the dif-
ferent anatomical sites, particularly at frequencies between 
1.2–39 kHz where the impedance was between 500–2,500 Ω. 
Table 2 gives a statistical comparison of the median spec-
tra for the nine anatomical sites and shows that there were 
significant differences in the median spectral data between 
many of the sites analyzed.
Patient data
Ten patients had OSCC lesions. Three of these affected 
the ventral tongue, two the floor of mouth, and one each 
the lateral tongue, dorsal tongue, buccal mucosa, vermil-
lion, and hard palate. EIS readings taken from the lesions 
of patients diagnosed with OSCC showed that 80% of 
these lesions had considerably lower impedance spectra 
when compared with the median spectra recorded from the 
same oral mucosal site in the control subjects (Figure 3). 
The median spectra for the normal compared with cancerous 
tissue showed substantial separation in the low-frequency 
Figure 3 Median impedance spectra from the 51 control subjects for each site analyzed within the mouth are plotted as solid lines. The spectra recorded from the 10 study 
subjects diagnosed with oral squamous cell carcinoma are plotted as dashed lines. The color coding allows each spectrum from the cancer group to be compared with the 
median spectra from the control group for the specific site in the mouth where each lesion was located. There were three oral squamous cell carcinoma affecting the ventral 
tongue (black), two affecting the floor of mouth (blue), and one each affecting the lateral tongue (yellow), dorsal tongue (cyan), buccal mucosa (green), lip vermillion (red), 
and hard palate (magenta).
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regions, particularly below 4.9 kHz, and in four cases, the 
impedance levels in the tumors did not read above baseline 
values of around 500 Ω.
eIs readings for lesion compared  
with control subjects
Data points in the scatterplots in Figure 4 each show the 
difference in the spectra obtained for the lesion compared 
with the control template spectra for the same anatomical 
site. For example, if a lesion measurement was taken from 
the hard palate, then it was matched with the control tem-
plate for the hard palate of control subjects. In Figure 4A, 
the lesion data have been categorized according to the WHO 
grading of OED. The EIS readings for the oral cancer, severe 
dysplasia, and moderate dysplasia lesions were significantly 
different from those obtained from the same anatomical site 
in the control subjects (P=0.0002, P=0.0338, and P=0.0067, 
respectively). In contrast, EIS readings from the mild dys-
plasia and benign lesions showed no significant difference 
from readings taken at the same anatomical site in controls. 
In Figure 4B, the lesion data were categorized according 
to the binary grading of OED. Significant differences were 
observed in the EIS readings for the oral cancer (P=0.0002), 
high-risk dysplasia (P=0.0057), and low-risk dysplasia 
(P=0.0253) lesions compared with readings from the same 
anatomical site in controls. In Figure 4C, the lesions were 
recategorized again into high-risk lesions (oral cancer + 
high-risk dysplasia) and low-risk lesions (low-risk dyspla-
sia and benign). Readings for the high-risk lesion group 
were significantly different from both the low-risk lesion 
group (P=0.0408) and the same anatomical site in controls 
(P=0.0001), but there was no significant difference in the 
readings taken from the low-risk lesion group and the same 
anatomical site in control subjects.
eIs readings for lesions compared  
with contralateral normal mucosa  
in the same patient
To determine whether the EIS readings taken from the 
lesions of study subjects were different from clinically 
appearing healthy mucosa from the same individual, EIS 
measurements from the lesions were matched to those 
taken from the same anatomical site but on the contralat-
eral side of the mouth (Figure 5). When the lesions were 
categorized according to the WHO grading of OED, EIS 
readings taken from oral cancers were significantly dif-
ferent from moderate dysplasia (P=0.0431), mild dyspla-
sia (P=0.0068), and benign (P=0.0288) lesions, but not 
from lesions with severe dysplasia. In addition, readings from 
severe dysplasia lesions were significantly different from 
benign lesions (P=0.033), but not significantly different 
when compared with moderate or mild dysplasia lesions 
(Figure 5A). When the lesions were recategorized using 
the binary grading of OED, significant differences in 
EIS readings were observed between oral cancers and 
low-risk dysplasia (P=0.0031) and benign (P=0.0288) 
lesions. A significant difference was also found between 
high-risk and low-risk dysplasia lesions (P=0.0222), 
but not between low-risk dysplasia and benign lesions 
(Figure 5B). When the lesions were recategorized again 
into high-risk lesions (oral cancer + high-risk dysplasia) 
and low-risk lesions (low-risk dysplasia + benign), EIS 
readings taken from the high-risk lesions were highly 
significantly different from readings taken from low-risk 
lesions (P=0.0009) (Figure 5C). We found no significant 
differences in the EIS readings taken from the nonlesional 
contralateral side of the mouth of patients and the same 
tissue site in control subjects.
Table 2 statistical comparison of the median eIs spectra for the anatomical sites of the oral cavity
Tissue n Median BM G LM V LT DT VT FM HP
BM 101 0.1323 Ns 0.0001 0.0003 0.0398 0.0001 0.0001 0.0001 Ns Ns
g 54 -0.110 0.0001 Ns Ns 0.0001 Ns 0.0001 Ns 0.0001 0.0004
lM 50 0.0084 0.0003 Ns Ns 0.0005 0.0109 0.0001 0.0045 0.0002 0.0038
V 27 0.2489 0.0398 0.0001 0.0005 Ns 0.0001 0.0001 0.0001 Ns Ns
lT 94 -0.138 0.0001 Ns 0.0109 0.0001 Ns 0.0001 Ns 0.0001 0.0001
DT 48 -0.4623 0.0001 0.0001 0.0001 0.0001 0.0001 Ns 0.0014 0.0001 0.0001
VT 47 -0.251 0.0001 Ns 0.0045 0.0001 Ns 0.0014 Ns 0.0001 0.0001
FM 47 0.2184 Ns 0.0001 0.0002 Ns 0.0001 0.0001 0.0001 Ns Ns
hP 32 0.2653 Ns 0.0004 0.0038 Ns 0.0001 0.0001 0.0001 Ns Ns
Notes: Base statistics for the spectral match measurements for the tissue types are given in columns 2 and 3 (N, number of measurement). The median match value given for 
each tissue type is derived by calculating the match to the mean of all 500 normal measurements. The confusion matrix given in columns 4–12 compares these median values 
for all nine tissue types. The P-values were calculated using a Mann–Whitney two-tailed nonparametric test. Entries shown as NS (not significant) are where P0.05.
Abbreviations: BM, buccal mucosa; G, gingiva; LM, labial mucosa; V, vermillion; LT, lateral tongue; DT, dorsum of tongue; VT, ventral tongue; FM, floor of mouth; HP, hard palate.
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Figure 4 scatterplots showing the difference in spectra between the lesion and the same-site median control spectra.
Notes: The results are grouped for each disease category, and the scatter on the 500 measurements made on the 51 normal subjects is also shown. The vertical axis on 
each scatterplot shows the match to the expected normal spectrum for each tissue type with the lesions categorized using (A) the World Health Organization classification 
system, (B) the binary oral epithelial dysplasia grading scheme, and (C) lesions divided into high-risk lesions and low-risk lesions. The mean and 95% confidence interval levels 
are shown for each group; significant differences were analyzed using a two-tailed, nonparametric Mann–Whitney U-test. *P0.05; **P0.01; ***P0.001.
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Figure 5 scatterplots showing the difference in spectra between the lesion and the spectra obtained from same-site normal tissue on the contralateral side of the patient’s mouth.
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classification system, (B) the binary oral epithelial dysplasia grading scheme, and (C) lesions divided into high-risk lesions and low-risk lesions. The mean and 95% confidence interval 
levels are shown for each group; significant differences were analyzed using a two-tailed, nonparametric Mann–Whitney U-test. *P0.05; **P0.01; ***P0.001.
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assessment of eIs performance
To assess the performance of the EIS measurements as a 
means of identifying disease, ROC curves were derived 
from the EIS data. Figure 6A examines the performance of 
EIS in distinguishing high-risk lesions (oral cancer + high-
risk dysplasia) from low-risk lesions (low-risk dysplasia + 
benign) when lesional spectra are compared with those from 
the same anatomical site in controls. It results in an area 
under the curve (AUC) of 0.674 (95% confidence intervals, 
0.518–0.830; P=0.0411). The point that is marked by the 
arrow equates to a sensitivity of 65.2%, a specificity of 
62.5%, and a positive likelihood ratio of 1.74 (Figure 6A). 
This point corresponds to the highest likelihood ratio that 
also gives sensitivity greater than 60%. When instead, 
lesional spectra were compared with normal oral mucosa 
on the contralateral side of the mouth (Figure 6B), the AUC 
for discriminating high-risk lesions from low-risk lesions is 
0.776 (95% confidence interval, 0.638–0.913; P=0.001). The 
point that is marked by the arrow corresponds to a sensitivity 
of 65.2%, a specificity of 91.7%, and a positive likelihood 
ratio of 7.83 (Figure 6B). Again, this point corresponds to 
the highest likelihood ratio that also gives sensitivity greater 
than 60%.
Procedure acceptability
Study subjects were asked to mark on a sliding scale from 
1 to 100 how painful and also how convenient the scalpel 
biopsy and EIS procedures were. Of study subjects, 85% 
rated the EIS measurements as having very low or no pain 
at all (a mark 20), whereas only 24% found the scalpel 
biopsy had this level of comfort. In contrast, only 2% of 
study subjects experienced severe pain (a mark of 60) 
with the EIS reading, whereas this level increased to 26% for 
the scalpel biopsy. Similarly, 89% of study subjects found 
the EIS measurement-taking procedure very convenient, 
whereas this value decreased to 41% for the scalpel biopsy 
procedure.
Discussion
Novel, noninvasive ways to discriminate among oral can-
cer, potentially malignant, and benign lesions are being 
developed to expedite diagnosis, improve monitoring of 
lesions, and reduce the need for biopsies, and so improve 
patient care. Current methods are based on improving lesion 
visualisation,15–18 imaging technology,19,20 or the use of brush 
biopsy followed by cytological analysis.28 However, recent 
studies have shown that normal oral keratinocytes and oral 
dysplastic and oral squamous cell carcinoma cell lines cul-
tured as both monolayers and as organotypic models can be 
distinguished from one another on their electrical impedance-
based properties.29–31 This suggests that impedance-based 
methods may have potential use in oral lesion diagnostics. 
We have recently shown that EIS can discriminate among 
normal tissue, cervical dysplasia, and early cervical cancer 
in the clinic.21 Therefore, this proof-of-concept study aimed 
to establish whether EIS could discriminate among normal 
healthy oral mucosa, oral PML, and oral cancer in patients 
in real-time.
Our results show clear differences in the median recorded 
electrical impedance spectra for normal oral mucosa at the 
nine different anatomical sites we studied in our control sub-
jects. Impedance is expected to fall with increasing frequency 
as more electrical current passes through the capacitance 
of the cell membranes. The rate at which this effect occurs 
Figure 6 receiver operating characteristic plots using (A) matches to the control subject data to compare high-risk lesions versus low-risk lesions (B) matches to the 
contralateral measurements to compare high-risk lesions versus low-risk lesions. Arrows indicate the points where the sensitivity and specificity were measured.
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will depend on cell shapes and sizes, as well as the spacing 
between cells. A highly structured tissue such as stratified 
oral squamous epithelium is expected to have higher imped-
ances at low frequencies because the epithelium consists of 
tightly bound cells. We anticipated that the median imped-
ance spectra would be particularly high in keratinized tissues 
but would be lower for nonkeratinized mucosa. We found 
that the impedance spectra recorded were consistent with 
this reasoning. For example, orthokeratinized tissues such 
as the vermillion and hard palate give the highest impedance 
readings, whereas nonkeratinized tissues such as the ventral 
tongue, lateral tongue, and labial mucosa give much lower 
readings (see Figure 3). Surprisingly, the specialized kerati-
nized mucosa of the dorsum of the tongue gave particularly 
low impedance readings. However, this may be because of 
the highly irregular structures (filiform and fungiform papil-
lae) found in this epithelium.
The electrode spacing used in the measurement probe 
dictates the depth to which current will penetrate the tissue. 
Modeling has shown that the tissue, down to a depth of about 
500 µm, will dominate the impedance spectrum.22 Cancer, 
severe and moderate dysplasia of squamous epithelia, dis-
rupts the normal epithelial architecture and stratification, and 
we would expect to see a decrease in the impedance mea-
surements for these lesions. We have previously observed 
such changes in readings taken from cervical squamous 
epithelium in the premalignant phases of disease.21,23,27 In the 
current study, measurements taken from oral cancer tissues 
also showed a large and significant (P0.0002) decrease 
in spectral impedances in the majority of cases we tested. 
This suggests that EIS has the potential to discriminate 
between normal healthy mucosa and cancerous tissue. The 
largest differences in impedance spectra between healthy 
and most cancer tissues were observed at low frequencies. 
Sun et al33 recently analyzed the bioimpedance of patients 
with tongue cancer over frequencies ranging from 20 Hz to 
5 MHz and compared these with the tongue readings taken 
from healthy controls. In their study, Sun and colleagues 
found that the differences in impedance readings between 
cancers and normal tissue were at their greatest at frequen-
cies between 20 Hz and 50 kHz.32,33 This is in agreement 
with the data presented in this study, although we found 
that the differences in spectra between cancerous and nor-
mal tissue extended to frequencies of up to 300 kHz, after 
which the spectra became similar. In addition, we found 
that the EIS readings for the oral cancer, severe dysplasia, 
and moderate dysplasia lesions were significantly different 
from those obtained from the same anatomical site in the 
control subjects. When we compared the lesional readings 
with those for same-site normal tissue on the contralateral 
side of the mouth, we found that the EIS readings from oral 
cancers were significantly different from those taken from 
moderate dysplasia, mild dysplasia, and benign lesions, 
but not from lesions with severe dysplasia. However, in 
this proof-of-concept study, EIS was unable to distinguish 
satisfactorily between the different grades of dysplasia and 
benign lesions or between benign and normal mucosa when 
analyzed using the WHO classification system. This may be 
because the architectural changes in the epithelium between 
these types of lesions are too subtle for the EIS device to 
detect or because the number of subjects in this study was 
inadequate to pick up any significant differences.
We recategorized the lesions, using the binary OED grad-
ing system. We did this for two reasons: first, there is increas-
ing evidence to show that the binary system has superior 
reproducibility and less inter- and intraexaminer variation in 
the grading of OED compared with the WHO system,12,34 and 
second, it is claimed that it is a better predictor of the potential 
for malignant change in a lesion.12,34 When recategorized, we 
found significant differences in the EIS readings for the oral 
cancer, high-risk and low-risk dysplasia lesions compared 
with the same anatomical site in controls. When instead we 
compared the lesional readings with those for the same-site 
normal tissue on the contralateral side of the mouth, we also 
found significant differences in EIS readings between oral 
cancers and low-risk dysplasia and benign lesions, as well 
as between high-risk and low-risk dysplasia lesions. Indeed, 
discrimination between adjacent grades of lesion was slightly 
better using the binary grading of OED compared with 
the WHO grading scheme. In part, this is likely to be because 
there are only four categories of lesion in the binary scheme 
compared with five in the WHO scheme. This means that 
the sample size increases in some categories and helps 
improve the significance of any difference in EIS readings 
between these categories.
Finally, we recategorized the lesions into two groups: 
high-risk lesions (oral cancers + high-risk dysplasia) and 
low-risk lesions (low-risk dysplasia + benign). We did 
this because this categorization is of some importance in 
distinguishing how lesions should be managed clinically. 
Most would consider that high-risk lesions need urgent 
intervention, with lesion excision as a minimum, whereas 
low-risk lesions are likely to be managed conservatively 
with risk modification and long-term monitoring for disease 
progression. Categorized in this way, EIS readings for the 
high-risk lesion group were significantly different from both 
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the low-risk lesion group and the same anatomical site in 
controls. However, when instead we compared the lesional 
readings with those for same-site normal tissue on the con-
tralateral side of the mouth, we observed highly significant 
differences in the EIS readings taken from high-risk lesions 
and low-risk lesions (P=0.0009). This is intriguing, as EIS 
matched data for contralateral versus control subjects showed 
no significant difference even though field characterization 
may be an issue in patients with PML.35 However, these data 
appear to suggest that taking measurements from the clini-
cally healthy-appearing oral mucosa on the contralateral side 
of the mouth to the oral lesion may act as a better control 
than median data collected from a healthy population. This 
may be because the control data are taken from the general 
population and will be composed of several compounding 
factors such as differences in age, ethnicity, and oral health 
that all have a profound influence on the oral mucosa. The 
median of these differences are unlikely to act as a better 
control than an individual’s own healthy oral mucosa in-
built control, which will be exactly age-matched, ethnically 
matched, oral health-matched, and risk factor-matched to 
the disease site. However, taken together, these data clearly 
show that the EIS device can distinguish high-risk lesions 
from low-risk lesions and so is likely to be a useful clinical 
aid in lesion management.
It is important to note that the matching method used to 
compare differences in each measured spectrum with either 
the same-site control subject template or the measurement 
from the patient’s contralateral side of the mouth does not 
distinguish between positive and negative changes in the 
spectra. Although Figure 3 shows that in the cancer group, 
the diseased spectra predominately show lower impedances 
than the control subjects, in some cases patients with dys-
plasia showed an increase in the measured impedances. This 
may reflect the differences in tissue architecture between 
these two groups, where dysplasia is composed of atypical 
epithelia cells on an intact basement membrane, whereas in 
oral carcinoma lesions, the basement membrane is breached 
by invading oral cancer cells. It is therefore likely that the 
EIS readings are different for dysplasia compared with cancer 
because of differences in the basement membrane structure 
that will dramatically alter the flow of electrical current. In 
contrast, this increase in impedance is not found in cervical 
premalignancy.27 The presence of inflammatory cells within 
malignant uroepithelium was reported to significantly change 
the impedance spectra compared with normal uroepithelium.36 
However, we did not observe such changes in this study, as 
there were no significant changes in the spectra of patients 
diagnosed with lichen planus (a condition in which marked 
numbers of inflammatory cells are present in the epithelium) 
compared with controls.
The ROC curve given in Figure 6B shows that the EIS 
data can be used to distinguish high-risk lesions from low-risk 
lesions with an AUC of 0.776. This figure may be compared 
with the AUCs quoted by Tidy et al21 of 0.740 and 0.783 for 
the EIS separation of high-grade cervical intraepithelial neo-
plasia from noncervical intraepithelial neoplasia.21 Figure 6B 
also shows that a sensitivity of 65.3% and a specificity of 
91.7% can be achieved in separating the high-risk and low-
risk lesion groups.
This study used an unblinded case-control study design 
with a small number of cases in each group, so it could be 
argued that review and selection bias may have a small but 
important effect on the data presented, and therefore the 
overall accuracy of the diagnostic test. Even so, the data 
shown in this relatively small proof-of-concept study is 
very encouraging and clearly shows that EIS can distinguish 
between cancer and normal oral epithelium and, more impor-
tant, between high-risk and low-risk lesions, and therefore 
has potential for use as a diagnostic tool to detect oral 
cancer or monitor oral PML. Moreover, the EIS procedure 
was found to be markedly more pain-free and convenient 
for patients compared with the scalpel biopsy. However, 
the study has also identified several areas for further work. 
The equipment used for recording the electrical impedance 
spectra was designed to take measurements from the cervix 
and not from the mouth. As a result, access to some oral 
tissue sites was problematic, and in these tissues it was dif-
ficult to ensure good contact for all four probe electrodes. 
This was especially evident for the hard palate because of 
the undulating surface of the rugae and the curved surface of 
the gingiva. This resulted in failure to record a spectrum in 
almost 10% of cases. Further spectra had to be rejected when 
they failed internal quality control checks by the device. The 
probe design needs to be modified to improve access to oral 
tissues and electrode contact with the oral mucosa. This 
would significantly increase the proportion of successful 
EIS readings. In addition, the lowest-frequency measure-
ments were subject to high errors and so had to be rejected 
from the analysis. It is possible that device sensitivity and 
specificity can be improved by selection of a frequency range 
more suited to oral use.
Construction of finite element computer models using 
data from the existing literature and from measurements 
made on a wide range of histopathology sections from oral 
squamous epithelium, different stages of dysplasia, and other 
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lesions could also be used to identify what changes will cause 
an increase in spectral impedance. These models could also 
be used to provide spectral templates to be used in clinical 
analysis of measured spectra.22 However, data presented in 
this study show a better separation of the diseased and control 
groups when comparing the lesion spectrum with a measure-
ment taken from the contralateral side of the mouth than when 
using the normal templates. Whatever the method of analysis 
to be used, a much larger prospective clinical trial is needed 
using a device specifically modified for oral use.
We conclude that EIS shows promise in helping to 
identify oral cancer and potentially malignant oral lesions 
in the primary care situation, for aiding decisions on lesion 
management, and also potentially for helping to identify the 
best site to biopsy and for monitoring lesions for disease 
progression over time.
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